MLS PHARMA: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MLS PHARMA
Largest movements
- Current investments +€97,015
new in 2025: €97,015
- Cash +€35,018
up €35,018 (+6.9%), from €509,600 to €544,618
mainly Net result for the year (+€197,555) and Other debts (+€120,161)
- Tangible fixed assets +€7,560
up €7,560 (+129.2%), from €5,853 to €13,413
of which Furniture and vehicles: +€5,535
- Profit (loss) carried forward +€186,945
up €186,945 (+76.0%), from €245,994 to €432,939
- Reserves -€169,390
no longer reported in 2025 (was €169,390)
of which Distributable reserves: -€169,390
- Other debts +€120,161
new in 2025: €120,161
- Taxes -€18,713
down €18,713 (-25.5%), from €73,468 to €54,754
- Gross operating margin +€15,214
up €15,214 (+6.3%), from €241,734 to €256,948
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €522,577 | €662,546 | +€139,969 | +26.8% |
| Fixed assets | 21/28 | €5,853 | €13,413 | +€7,560 | +129.2% |
| Tangible fixed assets | 22/27 | €5,853 | €13,413 | +€7,560 | +129.2% |
| Plant, machinery and equipment | 23 | €4,957 | €6,982 | +€2,025 | +40.8% |
| Furniture and vehicles | 24 | €896 | €6,431 | +€5,535 | +617.9% |
| Current assets | 29/58 | €516,724 | €649,134 | +€132,409 | +25.6% |
| Amounts receivable within one year | 40/41 | €3,629 | €2,047 | -€1,582 | -43.6% |
| Trade receivables | 40 | - | €2,047 | +€2,047 | |
| Other amounts receivable | 41 | €3,629 | - | -€3,629 | |
| Current investments | 50/53 | - | €97,015 | +€97,015 | |
| Cash at bank and in hand | 54/58 | €509,600 | €544,618 | +€35,018 | +6.9% |
| Deferred charges and accrued income | 490/1 | €3,495 | €5,454 | +€1,959 | +56.0% |
| Total equity and liabilities | 10/49 | €522,577 | €662,546 | +€139,969 | +26.8% |
| Equity | 10/15 | €415,384 | €437,939 | +€22,555 | +5.4% |
| Contributions | 10/11 | - | €5,000 | +€5,000 | |
| Reserves | 13 | €169,390 | - | -€169,390 | |
| Non-distributable reserves | 130/1 | €0 | - | = | |
| Distributable reserves | 133 | €169,390 | - | -€169,390 | |
| Profit (loss) carried forward | 14 | €245,994 | €432,939 | +€186,945 | +76.0% |
| Amounts payable | 17/49 | €107,193 | €224,607 | +€117,413 | +109.5% |
| Amounts payable within one year | 42/48 | €107,193 | €224,607 | +€117,413 | +109.5% |
| Trade debts | 44 | €58 | - | -€58 | |
| Suppliers | 440/4 | €58 | - | -€58 | |
| Taxes, remuneration and social security | 45 | €107,135 | €104,446 | -€2,689 | -2.5% |
| Taxes | 450/3 | €107,135 | €104,446 | -€2,689 | -2.5% |
| Other amounts payable | 47/48 | - | €120,161 | +€120,161 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €260 | €2,064 | +€1,804 | +694.5% |
| Other operating charges | 640/8 | €3,657 | €3,153 | -€504 | -13.8% |
| Gross operating margin | 9900 | €241,734 | €256,948 | +€15,214 | +6.3% |
| Operating profit (loss) | 9901 | €237,818 | €251,731 | +€13,914 | +5.9% |
| Financial income | 75/76B | €192 | €1,797 | +€1,605 | +835.2% |
| Recurring financial income | 75 | €192 | €1,797 | +€1,605 | +835.2% |
| Financial charges | 65/66B | €153 | €1,219 | +€1,066 | +697.3% |
| Recurring financial charges | 65 | €153 | €159 | +€6 | +3.9% |
| Non-recurring financial charges | 66B | - | €1,060 | +€1,060 | |
| Profit (loss) for the period before taxes | 9903 | €237,857 | €252,310 | +€14,453 | +6.1% |
| Income taxes | 67/77 | €73,468 | €54,754 | -€18,713 | -25.5% |
| Profit (loss) for the period | 9904 | €164,390 | €197,555 | +€33,166 | +20.2% |
| Profit (loss) for the period to be appropriated | 9905 | €164,390 | €197,555 | +€33,166 | +20.2% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 29 September 2026 via checked.be.